Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

The Zacks Analyst Blog Highlights C3.ai, UiPath, Microsoft, Alphabet and Amazon
The Zacks Analyst Blog Highlights C3.ai, UiPath, Microsoft, Alphabet and Amazon

For Immediate Release

Chicago, IL – May 14, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Best Growth Stocks to Buy for May 14th
Best Growth Stocks to Buy for May 14th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today May 14th:

Strattec Security STRT This company which designs, develops, manufactures and markets

VAALCO Energy to Execute Drilling Plans & FPSO Refurbishment in Africa
VAALCO Energy to Execute Drilling Plans & FPSO Refurbishment in Africa

VAALCO Energy EGY, a U.S.-based independent exploration and production firm, has outlined its plans related to oil and gas development at Côte d’Ivoire and Gabon in Africa. During its first-quarter

Local Bounti Corporation (LOCL) Reports Q1 Loss, Tops Revenue Estimates
Local Bounti Corporation (LOCL) Reports Q1 Loss, Tops Revenue Estimates

Local Bounti Corporation (LOCL) came out with a quarterly loss of $4.32 per share versus the Zacks Consensus Estimate of a loss of $1.31. This compares to loss of $2.89 per share a year ago. These

LeddarTech Holdings Inc. (LDTC) Reports Q2 Loss, Misses Revenue Estimates
LeddarTech Holdings Inc. (LDTC) Reports Q2 Loss, Misses Revenue Estimates

LeddarTech Holdings Inc. (LDTC) came out with a quarterly loss of $0.27 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.45 per share a year ago. These figures are

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.30 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.59 per share a year ago. These figures are

Alstom Stock: Sharp Plunge Amid Mixed Financial Results
Alstom Stock: Sharp Plunge Amid Mixed Financial Results

Alstom shares tumbled 14% to €19.50 on Wednesday following the release of its annual results, making it the worst performer on France's CAC 40 index. While the French train manufacturer managed to

Nucor Trades at Premium Valuation: Buy, Sell or Hold the Stock?
Nucor Trades at Premium Valuation: Buy, Sell or Hold the Stock?

Nucor Corporation NUE is currently trading at a forward price/earnings of 13.31X, a roughly 22% premium to the Zacks Steel Producers industry average of 10.9X. NUE is trading at a premium to Steel

Innospec's Earnings Surpass Estimates in Q1, Revenues Miss
Innospec's Earnings Surpass Estimates in Q1, Revenues Miss

Innospec Inc. IOSP recorded a profit of $32.8 million or $1.31 per share in first-quarter 2025, down from a profit of $41.4 million or $1.65 per share in the year-ago quarter.Barring one-time items

Best Value Stocks to Buy for May 14th
Best Value Stocks to Buy for May 14th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 14th:  

Strattec Security STRT: This company which designs, develops, manufactures and

Chicago Atlantic BDC, Inc. (LIEN) Reports Q1 Loss, Lags Revenue Estimates
Chicago Atlantic BDC, Inc. (LIEN) Reports Q1 Loss, Lags Revenue Estimates

Chicago Atlantic BDC, Inc. (LIEN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.34. This compares to loss of $0.01 per share a year ago. These figures

Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago. These

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates

Verve Therapeutics (VERV) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to loss of $0.59 per share a year ago. These figures

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.11 per share a year ago. These figures are

Bitfarms Ltd. (BITF) Reports Q1 Loss, Tops Revenue Estimates
Bitfarms Ltd. (BITF) Reports Q1 Loss, Tops Revenue Estimates

Bitfarms Ltd. (BITF) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.02 per share a year ago. These figures are adjusted for

AppLovin Surges on Earnings: What's Next for This Tech Standout?
AppLovin Surges on Earnings: What's Next for This Tech Standout?
[content-module:CompanyOverview|NASDAQ:APP]

Like a phoenix, AppLovin (NASDAQ: APP) has risen from the ashes in 2025, now solidly in the green for the year. 

The tech company’s latest earnings

Kamada (KMDA) Q1 Earnings Match Estimates
Kamada (KMDA) Q1 Earnings Match Estimates

Kamada (KMDA) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for

Radcom (RDCM) Q1 Earnings and Revenues Top Estimates
Radcom (RDCM) Q1 Earnings and Revenues Top Estimates

Radcom (RDCM) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago. These figures are

Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology

For Immediate Release

Chicago, IL – May 14, 2025 – Today, Zacks Equity Research discusses Cardinal Health CAH, Labcorp LH and Align Technology ALGN

Industry: Dental Supplies

Link: https://www.zacks.

E.ON Stock: Q1 Surge Boosts 2025 Outlook
E.ON Stock: Q1 Surge Boosts 2025 Outlook

The Essen-based energy giant E.ON has impressed investors with strong first-quarter results, triggering a notable stock price recovery. After facing a challenging period where shares lost nearly 7%

Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?
Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

How can you tell a good mutual

3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

The easiest, most reliable way

Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The easiest, most

Riskified (RSKD) Q1 Earnings and Revenues Top Estimates
Riskified (RSKD) Q1 Earnings and Revenues Top Estimates

Riskified (RSKD) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.04 per share a year ago. These figures

U.S. Regulators Target CrowdStrike: Is It a Signal or Noise?
U.S. Regulators Target CrowdStrike: Is It a Signal or Noise?
[content-module:CompanyOverview|NASDAQ:CRWD]

On May 9, CrowdStrike Holdings Inc. (NASDAQ: CRWD) closed the week down about 7%. A key reason for the sell-off was news that the company was part of